Predictive Utility of Patient-Reported Outcomes for Survival in 1st-Line Treated Patients with a NSCLC in EMPOWER-Lung 1 and 3

Basit Öğe Kaydı
dc.contributor.authorGandara, D. R.
dc.contributor.authorGogishvili, M.
dc.contributor.authorSezer, A.
dc.contributor.authorMakharadze, T.
dc.contributor.authorGuemues, M.
dc.contributor.authorMcIntyre, D. A.
dc.contributor.authorHe, X.
dc.date.accessioned2025-05-10T19:27:50Z
dc.date.issued2023
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstract[No abstract available]
dc.identifier.endpageS117
dc.identifier.issn1556-0864
dc.identifier.issn1556-1380
dc.identifier.issue11
dc.identifier.scopusqualityQ1
dc.identifier.startpageS117
dc.identifier.urihttps://hdl.handle.net/20.500.14730/7079
dc.identifier.volume18
dc.identifier.wosWOS:001098831600143
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherElsevier Science Inc
dc.relation.ispartofJournal of Thoracic Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectCemiplimab
dc.subjectAdvanced non-small cell lung cancer
dc.subjectPatientreported outcomes
dc.titlePredictive Utility of Patient-Reported Outcomes for Survival in 1st-Line Treated Patients with a NSCLC in EMPOWER-Lung 1 and 3
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu